关注
joão paulo morais de oliveira
joão paulo morais de oliveira
estudante de educação física, universidade ulbra canoas
在 rede.ulbra.br 的电子邮件经过验证
标题
引用次数
引用次数
年份
The UBIRIS. v2: A database of visible wavelength iris images captured on-the-move and at-a-distance
H Proença, S Filipe, R Santos, J Oliveira, LA Alexandre
IEEE Transactions on Pattern Analysis and Machine Intelligence 32 (8), 1529-1535, 2009
6402009
Females with Fabry disease frequently have major organ involvement: lessons from the Fabry Registry
WR Wilcox, JP Oliveira, RJ Hopkin, A Ortiz, M Banikazemi, ...
Molecular genetics and metabolism 93 (2), 112-128, 2008
6192008
COVID-19-related mortality in kidney transplant and dialysis patients: results of the ERACODA collaboration
LB Hilbrands, R Duivenvoorden, P Vart, CFM Franssen, MH Hemmelder, ...
Nephrology Dialysis Transplantation 35 (11), 1973-1983, 2020
4482020
Recommendations for initiation and cessation of enzyme replacement therapy in patients with Fabry disease: the European Fabry Working Group consensus document
M Biegstraaten, R Arngrímsson, F Barbey, L Boks, F Cecchi, PB Deegan, ...
Orphanet journal of rare diseases 10, 1-10, 2015
3782015
Nephropathy in males and females with Fabry disease: cross-sectional description of patients before treatment with enzyme replacement therapy
A Ortiz, JP Oliveira, S Waldek, DG Warnock, B Cianciaruso, C Wanner, ...
Nephrology Dialysis Transplantation 23 (5), 1600-1607, 2008
2752008
Prognostic indicators of renal disease progression in adults with Fabry disease: natural history data from the Fabry Registry
C Wanner, JP Oliveira, A Ortiz, M Mauer, DP Germain, GE Linthorst, ...
Clinical Journal of the American Society of Nephrology 5 (12), 2220-2228, 2010
2092010
European expert consensus statement on therapeutic goals in Fabry disease
C Wanner, M Arad, R Baron, A Burlina, PM Elliott, U Feldt-Rasmussen, ...
Molecular genetics and metabolism 124 (3), 189-203, 2018
2002018
Screening, diagnosis, and management of patients with Fabry disease: conclusions from a “Kidney Disease: Improving Global Outcomes”(KDIGO) Controversies Conference
R Schiffmann, DA Hughes, GE Linthorst, A Ortiz, E Svarstad, DG Warnock, ...
Kidney international 91 (2), 284-293, 2017
2002017
Renal outcomes of agalsidase beta treatment for Fabry disease: role of proteinuria and timing of treatment initiation
DG Warnock, A Ortiz, M Mauer, GE Linthorst, JP Oliveira, AL Serra, ...
Nephrology Dialysis Transplantation 27 (3), 1042-1049, 2012
1972012
Scoring system for renal pathology in Fabry disease: report of the International Study Group of Fabry Nephropathy (ISGFN)
AB Fogo, L Bostad, E Svarstad, WJ Cook, S Moll, F Barbey, L Geldenhuys, ...
Nephrology Dialysis Transplantation 25 (7), 2168-2177, 2010
1952010
Fibrosis: a key feature of Fabry disease with potential therapeutic implications
F Weidemann, MD Sanchez-Niño, J Politei, JP Oliveira, C Wanner, ...
Orphanet journal of rare diseases 8, 1-12, 2013
1912013
The effect of enzyme replacement therapy on clinical outcomes in male patients with Fabry disease: a systematic literature review by a European panel of experts
DP Germain, PM Elliott, B Falissard, VV Fomin, MJ Hilz, A Jovanovic, ...
Molecular genetics and metabolism reports 19, 100454, 2019
1842019
End-stage renal disease in patients with Fabry disease: natural history data from the Fabry Registry
A Ortiz, B Cianciaruso, M Cizmarik, DP Germain, R Mignani, JP Oliveira, ...
Nephrology Dialysis Transplantation 25 (3), 769-775, 2010
1662010
Time to treatment benefit for adult patients with Fabry disease receiving agalsidase β: data from the Fabry Registry
A Ortiz, A Abiose, DG Bichet, G Cabrera, J Charrow, DP Germain, ...
Journal of Medical Genetics 53 (7), 495-502, 2016
1652016
Eggplant (Solanum melongena) infusion has a modest and transitory effect on hypercholesterolemic subjects
PR Guimarães, AMP Galvão, CM Batista, GS Azevedo, RD Oliveira, ...
Brazilian Journal of Medical and Biological Research 33, 1027-1036, 2000
1572000
Mutations of the GLA Gene in Young Patients With Stroke: The PORTYSTROKE Study—Screening Genetic Conditions in PORTuguese Young STROKE Patients
MV Baptista, S Ferreira, T Pinho-e-Melo, M Carvalho, VT Cruz, ...
Stroke 41 (3), 431-436, 2010
1522010
How well does urinary lyso-Gb3 function as a biomarker in Fabry disease?
C Auray-Blais, A Ntwari, JTR Clarke, DG Warnock, JP Oliveira, SP Young, ...
Clinica chimica acta 411 (23-24), 1906-1914, 2010
1452010
Prevention of ventilator-associated pneumonia
J Oliveira, C Zagalo, P Cavaco-Silva
Revista portuguesa de pneumologia 20 (3), 152-161, 2014
1182014
Recommendations and guidelines for the diagnosis and treatment of Fabry nephropathy in adults
A Ortiz, JP Oliveira, C Wanner, BM Brenner, S Waldek, DG Warnock
Nature Clinical Practice Nephrology 4 (6), 327-336, 2008
1082008
The alpha-galactosidase A p. Arg118Cys variant does not cause a Fabry disease phenotype: data from individual patients and family studies
S Ferreira, A Ortiz, DP Germain, M Viana-Baptista, A Caldeira-Gomes, ...
Molecular genetics and metabolism 114 (2), 248-258, 2015
992015
系统目前无法执行此操作,请稍后再试。
文章 1–20